| Summary: | Precision medicine is the mainstream trend of contemporary medical development, and the neonatal intensive care unit (NICU) has become one of the important application scenarios of precision medicine. However, there is still an insufficient level of the clinical interpretation of disease genomes, and the bench-to-bedside translation of precision medicine in the NICU has not reached a satisfactory level. With reference to the current application of precision medicine in infants and young children, this article discusses how to achieve optimal results in the bench-to-bedside translation of precision medicine from the three aspects of emphasizing the early screening and diagnosis of genetic diseases, establishing a multi-omics integration platform, and applying machine learning techniques.
|
|---|